PHILADELPHIA, Jan. 5, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that its position with respect to alleged illegal manipulation of its stock by foreign business entities for purposes of bringing about a hostile takeover of the Company has been upheld by the U.S. Federal Court of Appeals.
